Answers are grounded in this paper and cite their sources.
Evaluates treatment-related features in patients with treatment-resistant schizophrenia, highlighting prognosis and treatment needs.
Background: The concept of difficult to treat schizophrenia (DTTS) was described about 25 years back. However, the prevalence of various features which make a patient with schizophrenia, difficult to treat has not been explored. Aim: The aim of the study was to evaluate the prevalence of various treatment-related features, which makes a patient DTTS. Methodology: For this study, 157 patients with treatment-resistant schizophrenia (TRS) were evaluated for various clinical features, which indicated that these patients were also having DTTS. Results: The most common criteria fulfilled by the participants were inadequate response to the atypical antipsychotics (96.8%), followed by poor medication adherence (75.8%) and having duration of untreated psychosis of more than 1 year (75.8%). About two-third (68.8%) of the participants also fulfilled the criteria of having experienced adverse effects due to the atypical antipsychotics (68.8%) and more than half (56.1%) of the participants reported inadequate response to typical antipsychotics. Other features seen in less than half of the participants were the presence of psychiatric comorbidity (43.3%), presence of treatment failure (relapse while on a dose of antipsychotic that previously had shown response) (40.8%), and adverse effects due to the typical antipsychotics (36.3%). Overall, 94.2% of the study participants fulfilled at least three abnormalities, and when the cut-off was raised to five abnormalities, the prevalence was 54.5%. When the cut-off of 6 features was used the prevalence of DTTS was 35.6%. Conclusions: Significant proportion of patients with TRS has three or more features of DTTS and an active evaluation for these factors during assessment and management of a patient with schizophrenia may help in better understanding of the prognosis and the treatment needs of the patients.
No takes yet. Share an insight, caveat, or question.
Grover et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: